Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$12.21 - $16.99 $272,283 - $378,876
-22,300 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$9.03 - $19.72 $69,531 - $151,844
-7,700 Reduced 25.67%
22,300 $298,000
Q2 2018

Aug 14, 2018

BUY
$10.79 - $24.44 $323,700 - $733,200
30,000 New
30,000 $544,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $423M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.